No Data
No Data
Angus (688581.SH): As of May 20, 2024, the number of shareholders in the company was 5,385
Gelonghui, May 21丨Anjess (688581.SH) said on an interactive platform that as of May 20, 2024, the number of shareholders of the company was 5,385.
Angus (688581.SH): As of May 10, 2024, the number of shareholders in the company was 5,168
Gelonghui, May 14 | Angel (688581.SH) said on an interactive platform that as of May 10, 2024, the number of shareholders of the company was 5,168.
About 15.3647 million restricted shares of Angus (688581.SH) will be listed and circulated on May 20
Angus (688581.SH) announced that the restricted shares listed and in circulation are limited to the company's initial public offering...
Angus (688581): 24Q1 profit exceeded expectations and is optimistic about high overseas growth
Core view The company's 2023 performance was in line with expectations, revenue growth in all product lines was high, and 2024Q1 profit growth exceeded expectations. Looking ahead to 2024, the company's revenue and profit are expected to grow steadily. In the short term, the company
We Think That There Are Issues Underlying HangzhouS MedTech's (SHSE:688581) Earnings
Unsurprisingly, Hangzhou AGS MedTech Co., Ltd.'s (SHSE:688581) stock price was strong on the back of its healthy earnings report. However, we think that shareholders may be missing some concerning de
Donghai Securities released a research report on April 24 stating that it gave Angus (688581.SH) a buy rating. The main reasons for the rating include: 1) performance growth exceeding expectations; 2) accelerated expansion of domestic and foreign markets;
Donghai Securities released a research report on April 24 stating that it gave Angus (688581.SH) a buy rating. The main reasons for the rating include: 1) performance growth exceeding expectations; 2) accelerated expansion of domestic and foreign markets; 3) significant increase in gross margin and increased profitability. (Mainichi Keizai Shimbun)
No Data